NEWS
NEWS
November 11, 2024
RION Awarded the Entrepreneur Award at the 11th Annual R.A.V.E
September 25, 2024
RION Expands Leadership Team with the Appointment of Five Renowned Experts to Advisory Boards
September 10, 2024
RION Announces Initiation of Phase 1b Clinical Study to Evaluate Purified Exosome Product™ (PEP™) for Knee Osteoarthritis
May 7, 2024
RION Announces First Patient Dosed in Phase 2 Clinical Study of Purified Exosome Product™ for Diabetic Foot Ulcers
February 26, 2024
RION Expands Manufacturing Operations with Cutting-Edge Facility in Rochester, Minnesota
February 23, 2024
RION to Present at the Evercore ISI 2024 Emerging Biotech Conference
January 30, 2024
RION Announces Initiation of Phase 2A Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers
January 2, 2024
RION to Present at the 42nd Annual J.P. Morgan Healthcare Conference
November 20, 2023
RION, Mayo Clinic, and the U.S. Army Medical Research Institute for Chemical Defense Recieved $2.4M Department of Defense Award to Advance Exosome-Based Research in Pulmonary Therapeutics
January 25, 2023